Scroll To Top
Search by Speciality

WCN 2015: ISN World Congress of Nephrology

CTICC: Cape Town International Convention Centre # | Cape town, SOUTH AFRICA
From 270 to 875 USD
Event Preview
Days Left
For the
Title: WCN 2015: ISN World Congress of Nephrology
Specialty: , Neurology, Pediatrics
Dates: From Mar, 13, 2015 to Mar, 17, 2015
Location: Cape town, SOUTH AFRICA
Type: Congress
Registration Cost: From 270 to 875 USD
Event Tools
  • Add to Favorites
  • Notify me by email
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for CAPE TOWN, South africa.
General Info
Event Venue:

CTICC: Cape Town International Convention Centre #

The Cape Town International Convention Centre Company (Convenco) is the holding company of the Cape Town International Convention Centre (CTICC). Convenco was formed in 1999 through collaboration between the City of Cape Town, the Provincial Government of the Western Cape and the business sector. It is jointly owned by the City of Cape Town (50.2% shareholding), the Provincial Government of the Western Cape (25.1% shareholding), and SunWest International (Pty) Ltd (24.7% shareholding). The primary objective behind the formation of the holding company was to deliver a world-class international convention centre in Cape Town that would provide meeting, convention and exhibition services and facilities for local and international organisations and their guests. It was envisaged by the Convenco co-founders that the CTICC would have a sustainable positive impact on the economic and social development of Cape Town, the Western Cape and South Africa as a whole.
Visit the Venue to read more
Event Overview
Welcome message:

ISN’s biennial World Congress of Nephrology (WCN) is the premiere educational event in nephrology which rotates between continents and is organized in collaboration with local and regional nephrology societies. The congress is targeted to the international nephrology community as well as other healthcare professionals involved in multidisciplinary nephrology care, thus enabling professionals from all parts of the world to exchange views on a wide variety of topics affecting nephrology and those suffering from kidney disease around the world.

By bringing together practicing physicians, academics, scientists, international health authorities and clinical researchers, each Congress offers a unique global forum for a free exchange of science and medical strategy and is aligned with local and regional reflections under the overall congress theme.

WCN aims to advance the education of physicians and other professionals, support the development of renal research, and facilitate the delivery of high-quality healthcare worldwide. Since ISN’s first congress in 1960, WCN has provided vital guidance and support to advancing nephrology around the world.

This edition of the World Congress will not only deliver the most recent innovations but also state-of-the-art knowledge that is relevant and adapted to renal care practice throughout the world where delegates benefit from practical, practice changing and concrete takeaways. It will feature a groundbreaking program with world renowned faculty, authoritative and innovative keynote lectures, scientific theme tracks, industry lunch symposia, poster sessions, an integrated industry exhibition, and last but not least magnificent social networking events full of culture and culinary delights.

On behalf of the International Society of Nephrology (ISN), the South African Renal Society (SARS), the African Association of Nephrology and the Renal Care Society of South Africa (RCSSA) we are pleased to invite you to participate in the 2015 World Congress of Nephrology under the theme of “Sustainability and Diversity”.

We look forward to seeing you in South Africa.

Giuseppe Remuzzi
ISN President & WCN 2015 Chair

Pierre Ronco
Scientific Program Committee Chair

Charles Swanepoel
Local Organizing Committee Chair


Planetary health: why health matters for human civilization 
Richard Horton (United Kingdom)

Richard Horton WebsiteRichard Horton is Editor-in-Chief of The Lancet.  He was born in London and is half Norwegian. He qualified in physiology and medicine from the University of Birmingham in 1986. He then joined The Lancet in 1990, moving to New York as North American Editor in 1993. Richard was the first President of the World Association of Medical Editors and he is a Past-President of the US Council of Science Editors.  He is an honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Oslo. He has also received honorary doctorates in medicine from the University of Birmingham, UK, and the University of Umea, Sweden. He is a Council member of both the UK’s Academy of Medical Sciences and the University of Birmingham. In 2011, he was appointed co-chair of the independent Expert Review Group overseeing delivery of the UN Secretary-General's Global Strategy of Women's and Children's Health. He is a Senior Associate of the UK health-policy think-tank, the Nuffield Trust. Richard received the Edinburgh medal in 2007 and the Dean’s medal from Johns Hopkins School of Public Health in 2009. In 2011, he was elected as Foreign Associate of the US Institute of Medicine. He has written two reports for the Royal College of Physicians of London: Doctors in Society (2005) and Innovating for Health (2009). He wrote Health Wars (2003) about contemporary issues in medicine and health, and he writes regularly for The New York Review of Books and the TLS. He has a strong interest in global health and medicine’s contribution to our wider culture.


Why and how aging makes us sick?
Tom Kirkwood (United Kingdom)

Tom Kirkwood WebsiteTom Kirkwood CBE is Dean for Ageing at Newcastle University and Director of the Newcastle Initiative for Changing Age, having previously been Director of the Institute for Ageing and Health from 2004-2011. Educated in biology and mathematics at Cambridge and Oxford, he worked previously at the National Institute for Medical Research and at the University of Manchester. His research is focused on the basic science of ageing and on understanding how genes as well as non-genetic factors, such as nutrition, influence longevity and health in old age. He is a Fellow of the Academy of Medical Sciences, Fellow of the Royal College of Physicians of Edinburgh and Honorary Fellow of the Faculty and Institute of Actuaries. He has published more than 300 scientific papers and received several international prizes for his research. His books include the award-winning ‘Time of Our Lives: The Science of Human Ageing’, ‘Chance, Development and Ageing’ (with Caleb Finch) and ‘The End of Age’ based on his BBC Reith Lectures in 2001.


Role of vaccines in making the world a better place for children 
Shabir A. Madhi (South Africa)

Shabir Madhi WebsiteShabir A. Madhi, MD, PhD, is Executive Director of the National Institute for Communicable Diseases, Professor of Vaccinology at the University of the Witwatersrand in Johannesburg, South Africa. He is also Director of the Respiratory and Meningeal Pathogens Research Unit and Research Chair in Vaccine Preventable Diseases of the Department of Science and Technology/National Research Foundation. Dr. Madhi completed his undergraduate and postgraduate training at the University of the Witwatersrand and qualified as a pediatrician in 1996 and is registered as a Pediatric Infectious Diseases specialist.

Dr. Madhi has been involved in research on vaccine-preventable diseases and on infections in HIV-infected children for 17 years. He has undertaken some of the pivotal studies that have led to policies and guidelines in South Africa and those issued by agencies such as the World Health Organization (WHO). His research demonstrating a reduction in childhood morbidity with the use of pneumococcal conjugate vaccines (PCVs) and rotavirus vaccines prompted South Africa to be the first in Africa to introduce these vaccines in national immunization programs. He is currently involved in epidemiological, immunological and clinical studies on immunization of pregnant women with influenza vaccine, pertussis vaccine and GBS vaccine; which are aimed at protecting young infants from disease. Dr. Madhi has contributed nine book chapters and over 175 peer reviewed articles.


Hypertension and kidney disease: the fault is not in our stars, but may be in our fetal nephrogenesis 
Barry M. Brenner (USA)

Barry Brenner WebsiteBarry M. Brenner earned his M.D. degree from the University of Pittsburgh School of Medicine in 1962, completed internal medicine residency at the Bronx Municipal Hospital Center, Albert Einstein College of Medicine in 1966 and continued his career in research positions at the National Heart Institute, and the University of California, San Francisco before arriving at Harvard as the Samuel A. Levine Professor of Medicine in 1976. Since then, Dr. Brenner has held various positions at the Brigham and Women's Hospital including: Director, Laboratory of Kidney and Electrolyte Physiology, Director, Renal Division 1979-2001 and since 2001, Director Emeritus. During his Directorship, the Brigham Renal Division was voted America’s leading nephrology program by U.S. News and World Report, a ranking that continues to the present day. His basic and clinical research has focused on mechanisms of glomerular function in health and disease, for which he is generally considered the world’s leading authority.

Dr. Brenner has served as officer in many societies including the American Society for Clinical Investigation (Councilor, Vice-President), American Society of Nephrology (Councilor, President), American Society of Hypertension (Founding Member, President), International Society of Nephrology (Councilor and Co-Chair, Commission for Global Advancement of Nephrology), American Association of Physicians (Councilor) and American Association for the Advancement of Science (Chair, Section on Medical Sciences). He has held 25 editorial board appointments, published more than 650 scientific articles, edited 48 books and has participated in over 300 visiting lectures and/or professorships. He has received numerous awards and accolades, including Fellow, Royal College of Physicians, London; Jean Hamburger Award and Amgen Prize, International Society of Nephrology; Richard Bright Award, American Society of Hypertension; Donald W. Selden and David M. Hume Awards of the National Kidney Foundation (USA); Novartis International Award, Council for High Blood Pressure Research, American Heart Assoc; and Homer W. Smith (Basic Science), John P. Peters (Clinical Science) and Robert G. Narins (Teacher/Educator ) Awards of the American Society of Nephrology (the sole recipient of all three major awards in the history of the Society. He has also received honorary degrees from Harvard University (A.M., 1977), Long Island University (D.Sc. 1987), Université de Paris, Pierre et Marie Curie (D. Med. Sci., 1992), Universidad Complutense de Madrid (M.D., 2002) and was named Distinguished Alumnus of the University of Pittsburgh in 1995. Dr. Brenner was elected to The American Academy of Arts and Sciences in 2003.


Epigenetics: finding the missing heritability of complex diseases 
Katalin Suszstak (USA)

Katalin Suszstak WebsiteKatalin Suszstak is a physician-scientist. Dr. Suszstak received integrated training as an MD/PhD followed by post-graduate training in Internal Medicine and in Nephrology. She also completed a Master of Clinical Research program to better understand clinical research study design and analysis. Currently Dr. Suszstak practices medicine and runs a research laboratory.

Work in the laboratory is aimed towards the understanding of molecular pathways that govern chronic kidney disease development. There are two general areas of interest: hypothesis generating (high through-put, translational) and mechanistic studies. Over the past 10 years the laboratory banked and analyzed (combined genetic, epigenetic and genomic approaches) a large number of healthy and diseased human kidney tissue samples. They hypothesize that integrative analysis of epigenetic and genetic settings in diseased cells can provide a rational basis for more accurately modeling the critical biological pathways involved in mediating the progressive phenotype in individual patients.

Currently there are 7 post-doctoral fellows and one graduate student in the laboratory. Recently one of the trainees, Dr. Kimberley Reidy received an NIH K08 award and started her independent laboratory. Over the years Dr. Suszstak has trained a large number of clinical and research fellows in her laboratory and is actively involved in different clinical and research training programs at the University of Pennsylvania.


Intestinal microbiota in health and disease 
Stanislav Dusko Ehrlich (France)

Stanislav Dusko Ehrlich WebsiteStanislav Dusko Ehrlich was trained in Organic Chemistry at the University of Zagreb, Croatia and obtained a PhD degree in Biochemistry at the University Paris VII, France. He was a research associate of Dr. Joshua Lederberg, Nobel Prize winner, in the Department of Genetics, Stanford University Medical School, California. He founded and directed Microbial Genetics Research Unit and the Microbiology Department at the National institute for Agricultural Research (INRA). He also founded a start-up company Enterome, developing microbiome-based biomarkers. He is Research Director Emeritus at INRA, Chief Scientific officer of Enterome and Professor at King’s College London.  His research interests are in Human Microbiome; he coordinated the EU-funded project MetaHIT and is the PI of the French Government Investissement d’Avenir 19 M€ grant MetaGenopolis. He authored or co-authored over 330 publications in peer-reviewed scientific journals, 50 book chapters and 10 patents and holds an H index of 71. He is a laureate of the career INRA Excellence of the Agricultural Research Award, member of the French Academy of Agriculture, Croatian Academy of Sciences and Arts, the European Molecular Biology Organisation and the American Academy of Microbiology and is Chevalier de l'Ordre National du Mérite and Légion d'Honneur.


Continuum from rare disorders to general population risk 
Olivier Devuyst (Switzerland)

Olivier Devuyst WebsiteOlivier Devuyst, MD, PhD, is Full Professor in the Institute of Physiology of the UZH and invited Professor at the Université catholique de Louvain (UCL) Medical School in Brussels, Belgium. He has a joint appointment in the Division of Nephrology of the USZ in Zurich and the Saint-Luc Academic Hospital in Brussels. Dr. Devuyst and his group investigate the molecular mechanisms of the transport of water and solutes across epithelia, and the pathophysiology of inherited renal tubular diseases and their progression. These studies, which have generated more than 200 peer-reviewed articles, are funded by national and international agencies, including the European Union (FP6, FP7), the Baxter Extramural Foundation and the National Institutes of Health. Dr. Devuyst has given more than 180 invited lectures and has been the laureate of several international prizes (including the Galien Prize in 2003, the International Spa Foundation Prize in 2007, and the Prix de la Fondation du Rein in 2009). He serves in the Editorial Board of Kidney International, Pflügers Archiv and Frontiers in Renal and Epithelial Physiology, and he is Associate/Speciality Editor of Peritoneal Dialysis International and Nephrology Dialysis Transplantation. Dr. Devuyst has been elected at the Royal Academy of Medicine of Belgium in 2005. Since 2010, he coordinates the Working Group on Inherited Kidney Disorders (WGIKD) of the European Renal Association (ERA-EDTA).

Registration Not yet available Register Now

Turners Conferences has been appointed as the Official Housing Bureau of WCN 2015 to provide a range of services for the event participants.


To ensure a smooth and enjoyable stay in Cape Town, you are strongly recommended to plan ahead. To book your hotels, optional events and local transportation and for more information about these services, please click the link below to access the official housing bureau website.

Scientific Content Up to Date
Submission Info

The organizers of WCN 2015 invite the nephrology community to submit abstracts to WCN 2015. Submissions for poster presentations (moderated poster sessions) as well as oral presentations in the Congress Scientific Symposia can be made. WCN Congress registration will be required for both presentation formats upon acceptance notification.

Opportunities for allied health professionals submitters exist for additional presentations during the pre-congress allied health professional symposium to be held on Friday March 13, 2015.


Abstract Submissions Open: July 14, 2014

Abstract Submissions Deadline: October 27, 2014 at 23:59 (Central European Time)


The organizers of WCN 2015 invite you to submit abstracts to WCN. Online submission can be made via this website as of July 14, 2014.


Abstracts should concern all aspects of nephrology, the treatment of renal disease or the scientific background to the study of the kidney.


A hard copy of the submitted abstract is NOT required for submission. All submissions must be made through the ISN WCN 2015 website.


You will receive an email within two (2) business days of submitting your abstract. If you submit on the date of the deadline and do not receive confirmation within 48 hours, please contact Shira Strachova at ISN via


The Presenting Author of each abstract accepted for publication/presentation at the Congress will be notified by November 28, 2014. The abstract submitters of accepted abstracts are entitled to register at the discounted registration fees provided they register by the early bird deadline ( December 14, 2014).

 If the Presenting Author is unable to present the abstract, another Co-Author can take his/her place. A letter from the Presenting Author informing about the change is requested and must be sent to the WCN 2015 Congress Office by February 13, 2015.


Submitted abstracts CANNOT be withdrawn or changed. No exceptions will be made.


Submitted abstracts must describe unpublished work which is not already in press and which is not awaiting possible acceptance by any other society that publishes its proceedings.


Accepted abstracts will be published electronically in a searchable database on the WCN 2015 and ISN websites as well as distributed onsite as a Abstract CD-ROM. No printed Abstract Book will be produced.


By submitting this abstract, the author assigns copyright to the ISN.


ISN supports the need to stop practices and policies of organ trafficking and tourism. Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the below policy documents. To be eligible to submit an abstract for the ISN WCN 2015, submitters must disclose that the author(s)/ scientist(s) have not violated any aspect of the following:

The Declaration of Istanbul on Organ Trafficking and Transplant Tourism Lancet. 2008 Jul 5;372 (9632):5-6.

For Live Kidney Donation - The Consensus Statement of the Amsterdam Forum(Transplantation 79(6): S53-S66, 2005).

For Live Donation of Extrarenal Organs - The Consensus Statement of the Vancouver Forum (Transplantation 81(4): 1373-1385, 2006).

For Studies of Xenotransplantation - The International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003).

For research involving human subjects - The Helsinki Declaration of The World Medical Association.

The Ethical Statements of the Transplantation Society, TTS Ethics Policy.

The TTS Ethics China.

The Ethical Statements of the International Xenotransplantation Association.


The abstract submission deadline is October 27, 2014 (23.59 CET) Abstracts received after the deadline will not be considered.


Abstracts will be considered for Moderated Poster Presentation or Oral Presentation (only limited slots are available for oral presentation during WCN 2015).

Abstract submitters may submit papers in one (1) of the following categories:


Communicable, Non-Communicable and other Renal Risk Factors

  • Diabetic Nephropathy – Experimental Models
  • Diabetes Mellitus (Clinical)
  • Hypertension-Clinical and Experimental Models, Renal Haemodynamics and Vascular Physiology
  • Infection and Renal Disease
  • HIV-Nephropathy


Acute Kidney Injury (AKI)

  • Acute Renal Failure – Experimental Models
  • Clinical Studies Including Toxic Nephropathy
  • Biomarkers for Acute Kidney Injury
  • Acute Renal Failure - Clinical


Translational and Clinical Nephrology

  • Cell Signaling, Cell Growth Control, Hormones and Cytokines
  • Renal Development and Cystic Disease (Aetiology)
  • Inherited Diseases and Molecular Genetics
  • GN – Experimental Models
  • Renal Pathology, Experimental Pathology, including Immune and Inflammatory Mechanisms
  • Other Renal Disease - Experimental Models
  • Primary Glomerular Disease Clinical
  • Secondary Glomerular Disease
  • Vasculitides Clinical
  • Tubulointerstitial Renal Disease, Stones, Urinary Infection
  • Paediatric Nephrology
  • Pregnancy and CKD
  • Supportive Care, including End-of-Life Issues
  • Clinical Nephrology Miscellaneous
Sponsors Exhibitors
Organising Agency
ISN World Congress of Nephrology 2015
Rue des Fabriques 1 B-1000 Brussels, Belgium
+32 2 808 04 20
+32 2 808 4454


Official Event Webpage
Event map
Revelant Events